Source comparison
Sermorelin Cycle: Protocol Comparison
Standard Clinical 200–250mcg 30 min before bed 12–16 weeks +30–40% from baseline Most validated approach. Aligns with natural GH pulse and demonstrates consistent results across multiple trials High-Dose Research 300–500mcg 8–12 weeks +35–50% from baseline Mar
This comparison does not assign a generated winner or score.
- Standard Clinical
- 200–250mcg
- 30 min before bed
- 12–16 weeks
- +30–40% from baseline
- Most validated approach. Aligns with natural GH pulse and demonstrates consistent results across multiple trials
- High-Dose Research
- 300–500mcg
- 8–12 weeks
- +35–50% from baseline
- Marginally better IGF-1 response but side effect incidence (flushing, headache) increases 2–3×. Diminishing returns above 300mcg
- Post-Workout
- 200–300mcg
- Immediately post-training
- +30–45% from baseline
- Effective but requires consistent training schedule. Response more variable than bedtime dosing
- Split-Dose
- 150mcg AM + 150mcg PM
- Morning fasted + before bed
- +25–35% from baseline
- Less commonly studied. Theoretically mimics diurnal GH pattern but no published data shows superiority over single bedtime dose